These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 720873)

  • 41. [Relation of placental prolactogen and E3 in the blood of pregnant women to placental grading by ultrasonography and its clinical significance].
    Wang SQ
    Zhonghua Fu Chan Ke Za Zhi; 1989 Jul; 24(4):220-3, 252-3. PubMed ID: 2695301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic possibilities of serum immunoreactive estriol (E3) in fetal hypotrophy of different etiology].
    Ananiev V
    Akush Ginekol (Sofiia); 1984; 23(3):220-5. PubMed ID: 6476277
    [No Abstract]   [Full Text] [Related]  

  • 43. [Relation between ultrasonic and hormonal parameters in fetal hypotrophy].
    Ruseva R; Marinov B
    Akush Ginekol (Sofiia); 1984; 23(1):52-6. PubMed ID: 6721116
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prognostic value of determining HPL for threatened fetuses during risk pregnancies].
    Simko J; Machánova Y
    Cesk Gynekol; 1982 Sep; 47(8):571-5. PubMed ID: 7139742
    [No Abstract]   [Full Text] [Related]  

  • 45. [Usefulness and limitations of hormonal monitoring of pregnancy with HPL and estriol in improving fetal prognosis and preventing neonatal neurologic deficiency].
    Paci S; Russo G; Mure G; Parisi R; de Filippo V; Correnti R; Eliamo A; Comis B; Latagliata C; Ventimiglia E
    Minerva Ginecol; 1989 Jun; 41(6):265-75. PubMed ID: 2475824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical studies of fetal growth retardation].
    Takeda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):153-8. PubMed ID: 6699444
    [No Abstract]   [Full Text] [Related]  

  • 47. [Contribution towards diagnostics of intrauterine fetal retardation (author's transl)].
    Kyank H
    Zentralbl Gynakol; 1980; 102(6):313-20. PubMed ID: 7467967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The small fetus: growth-retarded and preterm.
    Tambyraja RL; Ratnam SS
    Clin Obstet Gynaecol; 1982 Dec; 9(3):517-37. PubMed ID: 6756748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hypertension in pregnancy (author's transl)].
    Zander J; Goebel R; Kuhn W
    MMW Munch Med Wochenschr; 1974 Apr; 116(14):699-706. PubMed ID: 4209132
    [No Abstract]   [Full Text] [Related]  

  • 50. The prediction of fetal growth retardation in twin pregnancy.
    Houlton MC; Marivate M; Philpott RH
    Br J Obstet Gynaecol; 1981 Mar; 88(3):264-73. PubMed ID: 7470417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A pregnancy without detectable human placental lactogen (hPL)].
    Trapp M; De Wilde R; Holzgreve W; Stals HJ; Bohnet HG
    Zentralbl Gynakol; 1987; 109(2):130-3. PubMed ID: 3554836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study on blood level of human placental lactogen in abnormal pregnancy.
    Samanta B; Dutta GP
    J Indian Med Assoc; 1989 Sep; 87(9):205-7. PubMed ID: 2621369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The assessment of fetal well-being in intrauterine growth retardation syndrome (author's transl)].
    Weiss DB; Pugh C
    Harefuah; 1977 Nov; 93(10):288-91. PubMed ID: 604202
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of neonates born with intrauterine growth retardation: review and practice guidelines.
    Alkalay AL; Graham JM; Pomerance JJ
    J Perinatol; 1998; 18(2):142-51. PubMed ID: 9605307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biophysical and biochemical fetal monitoring].
    Richter R
    Gynakol Rundsch; 1984; 24 Suppl 1():102-7. PubMed ID: 6394440
    [No Abstract]   [Full Text] [Related]  

  • 56. The value of serum cystine aminopeptidase (CAP), human chorionic somato-mammotrophin (HCS), and urinary oestrogen assays for detecting intrauterine growth retardation.
    Rydén G
    Acta Obstet Gynecol Scand; 1978; 57(3):211-5. PubMed ID: 665162
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of fetal growth retardation.
    Beischer NA; Abell DA; Drew JH
    Med J Aust; 1977 Nov; 2(19):641-6. PubMed ID: 607101
    [No Abstract]   [Full Text] [Related]  

  • 58. Oxytocin challenge test and intrauterine growth retardation.
    Lin CC; Devoe LD; River P; Moawad AH
    Am J Obstet Gynecol; 1981 Jun; 140(3):282-8. PubMed ID: 7246629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor VIII related antigen/coagulant activity ratio as a predictor of fetal growth retardation: a comparison with hormone and uric acid measurements.
    Whigham KA; Howie PW; Shah MM; Prentice CR
    Br J Obstet Gynaecol; 1980 Sep; 87(9):797-803. PubMed ID: 6775686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrauterine growth retardation: report of case and review of literature.
    Irving WL
    J Am Osteopath Assoc; 1979 Mar; 78(7):488-93. PubMed ID: 429223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.